Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT: NCT05705973 · ACTIVE_NOT_RECRUITING
Brief Summary
The NAGOMI COMPLEX PMCF (Post-Market Clinical Follow-up) study has been designed to expand the knowledge about outcomes with the Ultimaster Nagomi™ sirolimus eluting coronary stent system (Ultimaster Nagomi™) in complex PCI subjects. The features for a complex PCI are based upon subgroup analysis of earlier published studies.
Frequently Asked Questions
What is Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients?
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients is a clinical trial registered under NCT05705973. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05705973?
The current status of NCT05705973 (Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients) is: ACTIVE_NOT_RECRUITING.
When did Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients start?
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients started on 2023-04-25.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.